(Q40251310)

18 September 2017

Efficient priming and expansion of antigen-specific CD8+ T cells by a novel cell-based artificial APC. (English)

1 reference

18 September 2017

Shigemi Sasawatari

1

1 reference

18 September 2017

Toshimasa Tadaki

2

1 reference

18 September 2017

Manami Isogai

3

1 reference

18 September 2017

Masashi Takahara

4

1 reference

18 September 2017

Mie Nieda

5

1 reference

18 September 2017

Kazuhiro Kakimi

6

1 reference

18 September 2017

20 July 2006

1 reference

Immunology & Cell Biology

18 September 2017

1 reference

18 September 2017

84

1 reference

18 September 2017

6

1 reference

18 September 2017

512-521

1 reference

T-cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes

18 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01462.X

Principles for adoptive T cell therapy of human viral diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01462.X

Cancer immunotherapy: moving beyond current vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01462.X

The ABCs of artificial antigen presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01462.X

An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01462.X

Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01462.X

Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01462.X

Expression and one-step purification of bovine interleukin-21 (IL-21) in silkworms using a hybrid baculovirus expression system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01462.X

Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01462.X

Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01462.X

Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01462.X

A cell-based artificial antigen-presenting cell coated with anti-CD3 and CD28 antibodies enables rapid expansion and long-term growth of CD4 T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01462.X

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01462.X

Part I: Vaccines for solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01462.X

Identification of tumor-specific antibodies in patients with breast cancer vaccinated with gene-modified allogeneic tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1711.2006.01462.X

10.1111/J.1440-1711.2006.01462.X

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference